In the current study, following the 2nd dose of the SARS-CoV-2 vaccine, CD4 naïve T cells were significantly decreased (p < 0.03), and CD8 TCM were significantly increased (p < 0.01) in the PAD patients. Here, CD8A is linked to peripheral arterial disease.